Specific HIV Medication Interactions: General
- ARV Alert (Regularly Updated)
Periodic updates on newly announced interactions involving HIV medications; each update features a brief synopsis of the interaction, as well as a chart outlining key information.
From HIV InSite
- Patient Information About Reyataz (Atazanavir) (PDF) (January 2013)
From Bristol-Myers Squibb Company
- Aspirin Dampens Immune Activation in HIV+ People on ART (August 10, 2012)
From HIVandHepatitis.com
- Are You a Good Interaction, or a Bad Interaction? (March/April 2012)
A guide to HIV drug interactions.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 Making Sense of the Drug Interaction Warning for HIV/HCV-Coinfected Patients Taking Victrelis: A Blog Entry by Barbara McGovern, M.D. (February 28, 2012)
From TheBody.com
- FDA Drug Safety Communication: Important Drug Interactions Between Victrelis (Boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs (February 8, 2012)
From U.S. Food and Drug Administration
- Results of Pharmacokinetic Study in Healthy Volunteers Given Victrelis (Boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected With Chronic Hepatitis C and HIV (February 6, 2012)
To read PDF, click here.
From Merck & Co., Inc.
- Elvitegravir/Cobicistat and Acid Reducing Agents (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Nelfinavir Interaction With Warfarin (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Intelence (Etravirine) Label Revised to Include New Drug-Drug Interaction Information (March 11, 2010)
From U.S. Food and Drug Administration
- Kaletra (Lopinavir/Ritonavir) Package Insert Revision Regarding Drug-Drug Interaction Information (January 29, 2010)
From U.S. Food and Drug Administration
- Information for Health Care Professionals: Update to the Labeling of Clopidogrel Bisulfate (Marketed as Plavix) to Alert Health Care Professionals About a Drug Interaction With Omeprazole (Marketed as Prilosec and Prilosec OTC) (November 17, 2009)
From U.S. Food and Drug Administration
- Sustiva + Ginkgo: Possible Recipe for Resistance, Doctors Report (May 21, 2009)
From aidsmap.com
- Warnings About Taking Reyataz With Sustiva, Viramune, Oral Contraceptives (August 21, 2008)
From U.S. Food and Drug Administration
- Acid-Reducing Agents Reduce Atazanavir Drug Levels but Not Lopinavir/Ritonavir Levels (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
- French Study Questions Interaction Between Atazanavir and Antacids (October 24, 2005)
From aidsmap.com
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- Efavirenz Reduces Plasma Levels of Popular Statins (July/August 2005)
From TheBodyPRO.com
- Antacids and HIV Medications (May/June 2005)
Over-the-counter antacids like Mylanta, Rolaids and Tums can decrease blood levels of some HIV meds.
In Survival News, from AIDS Survival Project
- Notice of Important New Drug Interactions With Norvir, Kaletra (March 30, 2005)
New interactions noted with fluticasone (a component of Flonase nasal spray) and trazodone (Desyrel, an antidepressant).
From U.S. Food and Drug Administration
On TheBodyPRO.com
- Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
To read PDF, click here.
From U.S. Food and Drug Administration
|
Advertisement
|
Email
Glossary
